Transcatheter Aortic Valve Replacement (TAVR) Market: April 2017 | Page 3

Global Transcatheter Aortic Valve Replacement (TAVR) Market: Analysis By Type of Approach (Transfemoral and Transapical), By Region, By Country: Opportunities and Forecast (2017-2022) Transcatheter aortic valve replacement (TAVR) has been a ground-breaking advancement in the field of interventional cardiology and cardiovascular surgery. Although, surgical aortic valve replacement is considered the standard treatment, yet 30% of patients are not considered candidates for traditional open heart surgery because of advanced age and presence of multiple comorbidities. Transcatheter aortic valve replacement offers this population a less invasive treatment option also with better outcomes. Over the recent years, the global TAVR industry has been growing rapidly mainly due to growing number of elderly population, rising awareness about minimally invasive devices, new device approvals and increasing health expenditure in developing countries. Company Profiles:- Edwards Lifesciences Corporation, Medtronic Plc, Boston Scientific Corporation, St. Jude Medical Inc., JenaValve Technology Inc., Meril Life Sciences Pvt. Ltd. Get a copy of Report @ http://www.reportsnreports.com/purchase.aspx?name=959972 Order this report by calling [phone] or Send an email to [email protected] with your contact details and questions if any. © ReportsnReports.com / Contact [email protected] 3